Select Page

Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market

WE BRING IN-DEPTH EXPERTISE IN THE MANUFACTURING OF YOUR MOLECULES

MONOCLONAL ANTIBODIES
RECOMBINANT PROTEINS
BIOSPECIFICS
ANTIBODY-DRUG CONJUGATES
NANO DRUGS

Customer-centric CDMO:
Discover our flexible manufacturing solutions for biopharma companies

Biologics CDMO

Expert process development and manufacturing services for a diversity of biotherapeutics.

Bioconjugates (ADC)

Flexible development and GMP manufacturing capacities for antibody-drug conjugates.

Nanodrugs CDMO

Integrated services for challenging API from formulation and development to GMP manufacturing.

Biologics CDMO: How we support your biopharmaceuticals

We’ve helped our customers develop and manufacture innovative therapies for more than 20 years.

“The team at BrainEver really valued working with GTP. They quickly captured our needs and came back with suitable solutions that fit our tight timelines. Their experience in protein production was, without question, a strong asset in moving from academia research into the inital development phases.”

Hubert Mechain, BrainEver

osivax_gtp_bioways

“With GTP Bioways, Osivax found a reliable GMP-compliant formulation and aspetic filling service provider. Their understanding of our needs, commitment to quality and customer-oriented focus were appreciated. They are also our partners for some R&D and analytical activities with relevant and problem-solving scientific discussions”

Imène Turki, Osivax

“We are happy to work with GTP Bioways for our very first clinical trial. This collaboration is a key point in the preparation of our clinical product before its administration to patients. With their brand-new facilities in Toulouse and their aseptic fill and finish operations, GTP Bioways shows all the guarantees requested for our lead anticancer compound ABD-3001 during our first-in-human clinical trial in acute myeloid leukemia upcoming soon. During the set-up of our GMP production, GTP Bioways team has been quite flexible and reactive to our needs “

Ismail Ceylan, Founder and CEO of Advanced Biodesign

“At European Vaccine Initiative, we have found GTP to be a very reliable partner. I specifically appreciated the intelligence their team put in the process development, going beyond merely executing our instructions.”

Nicolas Havelange, EVI

“GTP Nano is a flexible and reactive company with an high understanding of the development challenges for a biotech. Collaboration is easy, the teams are open to scientific discussions and collaborate with us about how to solve problems together. Very good partner for the development of new projects!”

Judith Greciet, Onxeo

“GTP is technically sound and client-oriented. We appreciated the mutual understanding between GTP and Xenothera and how GTP could adapt its offer to our needs.”

Bernard Vanhove, Xenothera

Our CDMO expertise spans all stages of biotherapetics development from R&D to commercial production

Years as a CDMO

Years' expertise in aseptic filling

Clients served worldwide

Protein programmes managed

White paper

A Guide to Smooth CDMO Tech Transfer

The key parameters to be considered while choosing your next CDMO, as well as our tips to assess those parameters, and more!

From our blog:Our biologics CDMO experience